Dr. Van Kampen conducted much of the preclinical research to validate bioactives present in Cerbella. She is the former Assistant Professor of Molecular Neuroscience at the Mayo Clinic College of Medicine, an Adjunct professor, Department of Biomedical Science at the University of Prince Edward Island. Her graduate training was completed at the Pacific Parkinson’s Research Centre and postdoctoral training at the Brain Repair Center at Dalhousie University.

Dr. Robertson graduated from the Universities of Western Ontario (B.A., M.Sc.) and Cambridge (Ph.D.) and is Professor Emeritus of Pharmacology at Dalhousie University. He is also an esteemed fellow of the Royal Society of Canada. Dr. Robertson was the First Neurofortis Visiting Professor at Lund University in Sweden and is also an Adjunct Professor at the University of Prince Edward Island. Dr. Robertson is co-founder of the Brain Repair Center (BRC) at Dalhousie University, and its first Director of Research. He is best known for discovering the role of the immediate early gene c-fos in brain and for his work on Parkinson’s and Huntington’s disease.

Dr. Kay has more than 25 years of experience in the development and characterization neurological conditions. He is a founder, and Chief Scientific Officer of Neurodyn Life Sciences, Inc. and is a grant recipient of the Michael J. Fox Foundation. Dr. Kay is a graduate of Dalhousie (B.Sc. and M.Sc.) and McGill (Ph.D.) Universities.

As a principal research scientist with Cerbella, Dr. Richard screens molecules for bioactivity in order to understand their mechanisms of action. Dr. Richard earned his master’s and doctoral degrees from the Department of Pharmacology at Dalhousie University. During his postdoctoral training at the University of Prince Edward Island, his research focus changed from cardiology to neurology as he investigated both Alzheimer’s disease and stroke.

As CEO, Ken is integral in all aspects of planning and development for Cerbella. He has over 25 years of experience working in biotechnology, and is putting his experience to work in order to bring safe and effective naturally-derived products to market.

As COO, Bob has spent his career identifying botanical extracts and natural active compounds that can provide healthier and more effective alternatives to existing treatments. He graduated from Purdue University, the University of Washington and received a Masters in Botany from the University of Wisconsin.

Dr. McLellan is a practicing naturopathic physician and provides a healthcare practitioner’s perspective on research and development at Cerbella. He is the co-author of two well-accepted books in the natural health field for the condition of diabetes and related neuropathy.